Obstetrics Pearls Flashcards
Typical gestational period
40 weeks
1st trimester timespan
0-12 weeks
2nd trimester timespan
13-27 weeks
3rd trimester timespan
28-40 weeks
1st trimester common symptoms/hx
Amenorrhea N/V Fatigue Breast tenderness Urinary frequency
Most common first symptom of pregnancy
Breast tenderness
2nd trimester common symptoms/hx
Fetal movement
Abdominal discomfort (d/t stretching)
Pigmentation changes (e.g. chloasma)
Syncope
3rd trimester common symptoms/hx
Abdominal growth
Braxton-Hicks contractions
Return of urinary frequency with descent of fetus
Increased work of breathing until descent
1st trimester PE findings (by 8 weeks)
Cervical softening
Cervical/labial bluish tint
Softening of cervicouterine junction
Breast enlargement
Fetal heart tones first audible
10-12 weeks
Goodell’s sign
Cervical softening
Chadwick’s sign
Cervical bluish tint, sign of increased perfusion
Hegar’s sign
Softening of cervicouterine junction
2nd trimester PE findings (by 18-20 weeks)
Striae
Fundus at level of umbilicus (i.e. 20 weeks), 1 cm/wk thereafter
Leopold maneuvers possible after 20 weeks
Leopold maneuvers
Manual determination of fetal position after 20 weeks
3rd trimester PE findings
Loss of mucus plug/blood show prior to labor by 1 week
Increased Braxton-Hicks, rupture of membranes
Lightening 3-4 weeks prior to labor
Pregnancy confirmatory
HCG
1st trimester diagnostics
UA, urine C and S, CBC, blood group and Rh, Ab screen, rubella (do not admin while pregnant) HbsAg, RPR, HIV, specialty, pap, cervical cultures, STI, U/S (for dating when unsure), chorionic villus sampling
2nd trimester dx wks 16-20
Triple/quad screen
Amniocentesis criteria/timeframe
h/o chromosomal abnormalities or AMA (wks 15-20)
Fetal survey timeframe
wks 18-20
1-hour GTT criteria/timeframe (2nd trimester)
h/o DM, wt >200 lbs @ 20 weeks
RhoGAM criteria/timeframe
Rh-unsensitized Rh-negative @ 28 weeks
Hgb/Hct timefrime
28-36 wks
Nonstress test/biophysical profile timeframe
3rd trimester PRN to eval fetus
HBV vaccine and group B strep test timeframe
3rd trimester
Earliest fetal viability (week)
24 weeks
Prenatal visit interval weeks 0-28
Q 4 weeks
Prenatal visit interval weeks 29-36
Q 2 weeks
Prenatal visit interval weeks 36+
Weekly
First OB visit priorities
Determine estimated date of confinement Personal, social, family hx Complete PE Routine labs FHT
Fetal heart tones timeframe to perform
10-12 weeks
Follow up OB visit priorities
Interval hx
PE, FHT, fundal height, movement, presentation/lie/position
Labs
Routine OB urine labs
Protein, glucose, ketones
Ectopic pregnancy defined
Conceptus implanted and grows outside uterine cavity (tubal 95%)
Ectopic pregnancy risk factors
Tubal surgery
H/o tubal ectopy
PID
IUD
Ectopic pregnancy sx/hx
Amenorrhea, abnormal dark/tarry spotting, abdominal/pelvic pain, unilateral LQP, LBP, shoulder pain, hemodynamic changes in VS
Ectopic pregnancy PE findings
Tender adnexa +/- palpable mass
+Chandelier sign (CMT)
+Hegar sign
+Peritoneal signs, vaginal bleed
Ectopic pregnancy work up
Serum hCG, CBC, type, Rh, U/S, preoperative labs
Ectopic management level
Emergent
Abortion timeframe
Prior to viability 24 weeks
Spontaneous abortion rate
15%
Spontaneous abortion timeframe
1st trimester
1st trimester spontaneous abortion cause
Chromosomal abnormalities
2nd trimester spontaneous abortion causes
Cervical incompetence, infection, uterine abnormalities
Unplanned pregnancy rate
50% of pregnancies
Spontaneous abortion sx/hx
Variable vaginal bleeding Cramping/pelvic pressure LBP rupture of membranes Hemodynamic changes in VS
Spontaneous abortion dx
hCG levels
U/S
CBC, type, Rh
Coag profile PRN
Spontaneous abortion management
Refer
Bed rest
Abstinence
Labs
Surgical abortion vacuum D and C timeframe
≤12 weeks
Surgical abortion D and E timeframe
13 to 14, 20 to 22
Medical abortion timeframe
≤49 days
Medical abortion agents
mifepristone, misoprostol
Pregnancy complications order of occurrence
PIH-preeclampsia-HELLP-eclampsia OR
PIH-preeclampsia-eclampsia-HELLP
Pregnancy induced HTN (PIH) defined
> 140/90 on 2 occasions
PIH incidence
12%
PIH risk factors
HTN, renal/CV dz DM SLE, autoimmune dz multigravida primagravida h/o of PIH Advanced/early parental age
PIH work up
BP surveillance
CBC/LFT, 24h urine protein, creatinine, CrCl
NST 32-34 wks
U/S PRN
PIH possible fetal effect
Delayed fetal growth (dx x u/s)
PIH management
Rest, bed rest LL recumbent
Fetal surveillance: NST u/s, kick counts at home
Preeclampsia weight gain
2lbs/wk or 6lbs/mo
Preeclampsia edema
Nondependent pretibial >1, +3-4; face, hands, feet (can’t get shoes on, rings off, etc)
Preeclampsia headache distribution
frontal or occipital HA
Preeclampsia advanced finding
Visual disturbance
Preeclampsia defined
PIH + proteinuria ≥trace, ≥2 severe
Preeclampsia fundal height
Retarded
Preeclampsia reflexes
WNL; 3-4+ in severe
Preeclampsia management
Referral Strict bed rest LL recumbent Fetal surveillance: NST, BPP, u/s Home kick counts Weekly betamethasone injections <34 weeks
Preeclampsia severe management
Hospitalization, MgSO4 therapy, induced delivery >34 wks or 2 doses betamethasone
Preeclampsia B-methasone function
Fetal lung maturity
Eclampsia defined
PIH + preeclampsia + tonic-clonic seizure
Eclampsia prodrome
Severe, unrelenting HA
Acute epigastric, RUQ pain
Visual disturbance, spotty vision, blurry, blind
Eclampsia findings
BP >160/100
Tonic-clonic seizure
Oliguria/anuria
Fetal distress in utero
Eclampsia dx
CBC, LFT, CMP, coag, 24 h urine for protein, CrCl, uric acid
Hospital fetal surveillance
Eclampsia management
MgSO4/valium to break sz
Induced labor stat
HELLP syndrome
Hemolysis, elevated liver enzymes, low platelets
HELLP syndrome s/s
PIH+preeclampsia+ n +/- vom, jaundice, extreme fatigue, malaise
HELLP PE findings
Hepatomegaly, RUQ pain radiating to epigastric, jaundice, ascities, spider nevi, ecchymosis, other liver findings
HEELP work up
Preeclampsia + thrombocytopenia, clotting factors, severe hemoconcentration, very elevated LFTs, proteinuria c/w severe preeclampsia
HELLP management
Emergent, hospitalization, delivery stat
Placenta previa defined
Mal-implantation of placenta in lower uterine segment, partial or complete cervical OS
Abruptio placentae defined
Separation of placenta from uterine wall complete/partial
Placenta previa bleeding
Often in late 2nd-3rd trimester w/vaginal intercourse
Placenta previa risk factor
H/o c-section, multiparous, malpresentation, h/o previa
Abruptio placentae acuity level
Emergent
Abruptio placentae sequelae
Fetal demise very likely complete>partial
Abruptio placentae bleed
Possibly life-threatening hemorrhage in 2nd-3rd trimester
Abruptio placentae bleed complication
disseminated intravascular coagulation (DIC)
Placental abruption risk factors
Trauma, chronic HTN, PIH, eclampsia, stimulant use, EtOH, cigarettes
Placenta previa s/s
Painless bleed, immediately after coitus OR no precipitating factor
No e/o ctx
No uterine tenderness
Little to no fetal compromise unless severe bleed
Placenta previa Dxs
U/S to ID location of placenta implantation
EFM to r/o fetal distress
CBC if serious bleed
Placenta previa management
NO bimanual, spec only Hospitalize NST/BPP while in hospital then weekly Total vaginal rest Anticipate delivery if possible
Placental abruption s/s
Severe abdominal pain Heavy BRB by vagina OR minimal if abruption is concealed Rigid uterus if concelead Shock Fetal distress, absent FHTs
Placental abruption dx
U/S to ID location of placenta implantation
EFM to r/o fetal distress
CBC, type, Rh for transfusion, coag profile
Placental abruption management
Emergent OB admit
Immediate delivery
Preterm labor defined
Ctxs >20 weeks <37 weeks resulting in effacement/dilation
Preterm labor s/s
Uterine cramping, LBP intermittent/rhythmic, uterine ctx 10-12 mins 5/hr
Vaginal spotting/discharge
Effacement/shortening/dilation
Preterm labor management
Tocolytic therapy if +cervical changes Hospitalization if unable to stop ctxs <34 weeks + successful tocolytics give b-methasome BIW until 34 wks Bed rest Vaginal and bed rest Weekly cervical checks
Postpartum complications
Pulmonary embolism
PP hemorrhage
PP depression
Mastitis (2/2 staph)
Mastitis management
Sx treatment (NSAIDs, ice) abx (dicloxacillin, cephalexin, clinda)